A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage
Clinical trial NCT05970224 · COMPLETED
Trial details
- NCT number
- NCT05970224
- Sponsor
- Bioxodes S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-17
- Primary completion
- 2026-03-20
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.